8X Recovery Blend Research Guide — 8-Component Lipotropic & Metabolic Panel: Carnitine, Arginine, Methionine, Inositol, Choline, B6, B5, B12 (2026)
- The 8X Recovery Blend (YPB.267) is an eight-component lipotropic and metabolic panel research combination: L-Carnitine (20mg) + L-Arginine (20mg) + Methionine (25mg) + Inositol (50mg) + Choline (50mg) + Vitamin B6 / Pyridoxine (25mg) + Vitamin B5 / Pantothenic Acid (5mg) + Vitamin B12 / Cyanocobalamin (1mg). Like the 4X Recovery Blend, this is a lipotropic amino acid, nutrient, and vitamin combination — not a peptide blend. Research Use Only (RUO).
- The 8X builds on the 4X by adding four additional components: L-Arginine (NO synthesis; urea cycle; protein synthesis), Inositol (IP3 second messenger; insulin signaling; phospholipid synthesis), Vitamin B6 (pyridoxal phosphate for transaminases and CBS homocysteine transsulfuration), and Vitamin B12 (methylcobalamin for methionine synthase; homocysteine remethylation cycle completion). Together the eight components cover the complete methylation cycle (Methionine + B12 + Choline), the homocysteine disposal routes (transsulfuration via B6; remethylation via B12/BHMT), mitochondrial FA transport (Carnitine), lipid second messenger signaling (Inositol), NO pathway (Arginine), and CoA biosynthesis (B5/Pantothenic Acid).
- Research rationale: the one-carbon methylation cycle is a tightly interdependent system. SAM (from methionine) donates methyl groups → SAH → homocysteine → either remethylated (B12/methionine synthase or BHMT/choline-betaine) or transsulfurated (B6/CBS → cystathionine → cysteine → glutathione). The 8X blend provides complete coverage of all entry and exit points of this cycle, making it a comprehensive one-carbon metabolism research tool that the 4X blend does not fully cover (missing B12 and B6). Updated April 2026. Research Use Only (RUO).
- Research applications: complete methylation cycle research, homocysteine metabolism, hepatic steatosis models, mitochondrial FA oxidation, inositol/PI3K signaling, arginine/NO biology, comprehensive lipotropic panel studies. Download the full catalog for all blend pricing.
What Is the 8X Recovery Blend and How Does It Expand on the 4X?
Complete Methylation Cycle Coverage
Not a Peptide Blend
The 8X Recovery Blend is the expanded version of the lipotropic research toolkit. Updated April 2026. Where the 4X provides the four core lipotropic pathways (methyl donor, VLDL export, FA mitochondrial transport, CoA biosynthesis), the 8X extends to eight components that collectively cover the entire one-carbon methylation cycle, both homocysteine disposal pathways, mitochondrial fatty acid transport, phospholipid/IP3 second messenger signaling, nitric oxide synthesis, and B-vitamin cofactor availability for all key metabolic enzymes in these pathways.
The 8X blend is designed for research contexts where studying the complete methylation cycle — not just the methyl donor input — is required. The 4X provides methionine and choline but does not provide the B12 and B6 cofactors that are required for the homocysteine disposal steps that complete the cycle. Without B12 (methionine synthase) and B6 (cystathionine beta-synthase), a research system supplied with only methionine + choline could accumulate homocysteine if the disposal enzymes are cofactor-limited. The 8X eliminates this cofactor limitation.
Complete Composition
| Component | Dose | Classification | Primary Metabolic Role |
|---|---|---|---|
| L-Carnitine | 20mg | Amino acid derivative (from Lys + Met) | CPT1/CPT2 carnitine shuttle; long-chain FA transport into mitochondrial matrix for β-oxidation |
| L-Arginine | 20mg | Semi-essential amino acid | NOS substrate → nitric oxide synthesis; urea cycle (arginase → ornithine + urea); protein synthesis; creatine precursor |
| Methionine | 25mg | Essential sulfur amino acid | SAM synthesis → universal methyl donor; PEMT pathway; carnitine precursor (methyl group); homocysteine source |
| Inositol | 50mg | Sugar alcohol (cyclohexanehexol) | Phosphatidylinositol (PI) synthesis; IP3/DAG second messenger cascade; insulin receptor signaling; myo-inositol trisphosphate; hepatic lipid transport |
| Choline | 50mg | Essential quaternary ammonium nutrient | Phosphatidylcholine/VLDL assembly; betaine (BHMT pathway: homocysteine remethylation); acetylcholine precursor; one-carbon metabolism |
| Vitamin B6 (Pyridoxine) | 25mg | Water-soluble vitamin (pyridoxine) | Pyridoxal phosphate (PLP) cofactor: CBS (cystathionine beta-synthase; homocysteine transsulfuration → cystathionine → cysteine → GSH); transaminases; DOPA decarboxylase |
| Vitamin B5 (Pantothenic Acid) | 5mg | Water-soluble vitamin (B5) | CoA biosynthesis; acyl-CoA (FA activation); acetyl-CoA (TCA); malonyl-CoA (FA synthesis) |
| Vitamin B12 (Cyanocobalamin) | 1mg | Water-soluble vitamin (cobalamin) | Methylcobalamin cofactor for methionine synthase: homocysteine + 5-MTHF → methionine (completes methylation cycle); also methylmalonyl-CoA mutase (odd-chain FA oxidation) |
The Complete One-Carbon Methylation Cycle Coverage
The methylation cycle’s dependency on multiple B-vitamins and essential nutrients makes it challenging to study in research models without ensuring complete cofactor provision. The 8X blend provides every component needed:
Methionine (25mg) → SAM (via MAT; methionine adenosyltransferase) → methyl group donation to over 100 acceptors → SAH → hydrolysis → homocysteine
Homocysteine is then disposed via two routes: (1) Remethylation: homocysteine + 5-methyltetrahydrofolate → methionine, catalyzed by methionine synthase, requiring B12 (Cyanocobalamin; 1mg) as methylcobalamin cofactor; OR via the BHMT pathway: homocysteine + betaine (from Choline; 50mg, oxidized to betaine) → methionine + dimethylglycine; (2) Transsulfuration: homocysteine + serine → cystathionine, catalyzed by CBS (cystathionine beta-synthase), requiring B6 (Pyridoxine; 25mg) as PLP cofactor → cystathionine → cysteine → glutathione.
The 8X blend provides: the methyl donor entry point (Methionine), both remethylation routes (B12 for methionine synthase; Choline/betaine for BHMT), and the transsulfuration disposal route (B6 for CBS) — the complete cycle. The 4X blend provides only the methyl donor (Methionine) and BHMT substrate (Choline) without the enzymatic cofactors (B12 for methionine synthase; B6 for CBS) that complete both disposal routes.
Key Research Applications
Complete Methylation Cycle and Homocysteine Research
The 8X blend’s unique value over the 4X is complete methylation cycle coverage with both homocysteine disposal routes (B12/remethylation + B6/transsulfuration). This makes it the appropriate tool for studying: hyperhomocysteinemia models (elevated homocysteine from B12 or folate deficiency); cardiovascular risk associated with elevated homocysteine; CBS deficiency models (homocystinuria); DNA and histone methylation changes from SAM availability; glutathione synthesis from transsulfuration (cysteine → GSH).
Comprehensive Hepatic Steatosis Panel
Adding B12 and B6 ensures that supplementing methionine and choline in hepatic steatosis models does not create secondary homocysteine accumulation from bypassed disposal steps. The 8X is the appropriate tool for complete MCD diet rescue experiments where cofactor insufficiency should not be a confounding variable.
Inositol/Insulin Signaling Research
Inositol (50mg; the highest-dose component in the 8X) supports phosphatidylinositol synthesis and provides substrate for the IP3/PI3K second messenger system. In cell culture models, inositol supplementation has been studied for effects on insulin receptor sensitivity (the PI3K/Akt pathway downstream of insulin receptor activation requires PIP3 generated from PI). The 8X blend’s inositol component adds this insulin signaling dimension not present in the 4X.
Arginine/NO Biology
L-Arginine (20mg) provides the substrate for NO synthesis by all NOS isoforms. Research models studying endothelial NO production, vascular tone, or iNOS-mediated inflammatory NO in hepatic or metabolic contexts benefit from the arginine inclusion in the 8X blend.
8X vs. 4X vs. KLOW: Catalog Comparison
| Parameter | 8X Recovery (YPB.267) | 4X Recovery (YPB.268) | KLOW Blend (YPB.264) |
|---|---|---|---|
| Type | Lipotropic nutrient/vitamin blend (8 components) | Lipotropic nutrient blend (4 components) | Peptide blend (4 peptides) |
| Unique components | L-Arginine, Inositol, B6, B12 (not in 4X) | Dexpanthenol (not in 8X) | GHK-Cu, KPV, BPC-157, TB-500 (all peptides) |
| Methylation cycle coverage | Complete: Methionine (SAM) + Choline/betaine (BHMT) + B12 (methionine synthase) + B6 (CBS transsulfuration) | Partial: Methionine + Choline only (no B12/B6 for cycle completion) | No methylation coverage (peptide repair blend) |
| NO pathway | Yes (Arginine) | No | No |
| PI3K/inositol signaling | Yes (Inositol) | No | No |
| Best for | Complete methylation + lipid metabolism + insulin signaling + NO research | Focused lipotropic FA/CoA/methylation research | Multi-pathway peptide anti-inflammatory + tissue repair research |
Key Research Notes
- 8 components, 8 metabolic roles: Carnitine (CPT1/2 FA transport) + Arginine (NOS/NO; urea cycle) + Methionine (SAM methyl donor) + Inositol (PI/IP3/PI3K signaling) + Choline (phosphatidylcholine/VLDL; BHMT methylation) + B6 (PLP/CBS transsulfuration) + B5 (CoA biosynthesis) + B12 (methionine synthase; methylation cycle completion).
- Complete methylation cycle: Methionine (SAM donor) + B12 (remethylation via methionine synthase) + Choline/betaine (remethylation via BHMT) + B6 (transsulfuration via CBS). 4X provides only Methionine + Choline without the cofactors.
- Inositol (50mg; highest dose): PI/PI3K substrate; IP3/DAG second messenger; insulin receptor signaling (PIP3/Akt); hepatic lipid transport.
- B12 at 1mg (cyanocobalamin): Methionine synthase cofactor (methylcobalamin); small dose provides research-level cofactor availability; also methylmalonyl-CoA mutase for odd-chain FA.
- B6 at 25mg (pyridoxine): CBS cofactor (homocysteine transsulfuration); also >100 other PLP-dependent enzyme reactions (transaminases, DOPA decarboxylase).
- Not a peptide blend: All 8 components are amino acids, essential nutrients, or vitamins; clearly labeled as lipotropic metabolic panel.
- 8X = comprehensive; 4X = focused: Use 4X for targeted lipotropic pathway studies; use 8X when complete methylation cycle integrity and inositol/arginine pathway coverage are required.
Market Demand and Catalog Positioning
| Demand Indicator | 8X Recovery Blend Data Point |
|---|---|
| Research context | Complete methylation cycle; homocysteine metabolism; NAFLD; insulin signaling + lipid metabolism intersection; arginine/NO; comprehensive metabolic panel |
| Unique catalog position | Most comprehensive YPB lipotropic blend; includes B12 and B6 for complete methylation cycle coverage; inositol for PI/IP3 signaling; arginine for NO pathway |
| Progression value | 4X Recovery → 8X Recovery is natural upgrade for researchers who need methylation cycle completion or insulin signaling coverage |
| Recognition | Similar to “MIC+ blend” lipotropic injection formulations well-recognized in integrative compound research community |
| Keyword difficulty range | Low (KD <5); integrative metabolic research niche |
Wholesale Pricing & White-Label Information
| SKU | Product | Premier ($497/mo) | Core ($297/mo) | MSRP |
|---|---|---|---|---|
| YPB.267 | 8X Recovery Blend (Carnitine + Arginine + Methionine + Inositol + Choline + B6 + B5 + B12) | TBC Premier | TBC Core | TBC |
Contact the YPB team for confirmed Premier and Core pricing. Use the YPB Profit Calculator to model projected revenue. Download the full catalog for all metabolic blend pricing. Pairing the 4X and 8X blends gives white-label brands the complete lipotropic research offering: focused (4X) and comprehensive (8X).
Methodology & Data Sources
Scientific literature: Well-established biochemical literature on one-carbon methylation cycle, homocysteine metabolism, carnitine shuttle, inositol/PI3K signaling, arginine/NO synthesis, and B-vitamin biochemistry. PubMed searched through April 2026. This article is for educational purposes only.
References
- Stipanuk, M. H. (2004). Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine. Annu Rev Nutr, 24, 539–577.
- Zeisel, S. H., & da Costa, K. A. (2009). Choline: an essential nutrient for public health. Nutr Rev, 67(11), 615–623.
- Mentch, S. J., & Locasale, J. W. (2016). One-carbon metabolism and epigenetics. Nat Genet, 48(5), 458.
- Nestler, J. E., et al. (1999). Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. N Engl J Med. (Inositol/insulin signaling context.)
- Morris, S. M. (2004). Enzymes of arginine metabolism. J Nutr, 134(10 Suppl), 2743S–2747S. (Arginine/urea cycle/NOS.)
- Refsum, H., et al. (2004). The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease. J Nutr. (B12/B6 homocysteine metabolism.)
- Longo, N., et al. (2006). Disorders of carnitine transport. Am J Med Genet. (CPT1/CPT2 carnitine shuttle.)
- Leonardi, R., et al. (2005). Coenzyme A: back in action. Prog Lipid Res. (Pantothenic acid/CoA.)
Frequently Asked Questions
The 8X Recovery Blend (YPB.267) is an eight-component lipotropic and metabolic panel research combination: L-Carnitine (20mg; CPT1/2 fatty acid mitochondrial transport) + L-Arginine (20mg; NOS/NO synthesis; urea cycle) + Methionine (25mg; SAM methyl donor; methylation cycle entry) + Inositol (50mg; PI/IP3/PI3K second messenger; insulin signaling) + Choline (50mg; phosphatidylcholine/VLDL; betaine/BHMT homocysteine remethylation) + Vitamin B6/Pyridoxine (25mg; PLP/CBS homocysteine transsulfuration; transaminases) + Vitamin B5/Pantothenic Acid (5mg; CoA biosynthesis) + Vitamin B12/Cyanocobalamin (1mg; methionine synthase; methylation cycle completion). Classification: lipotropic amino acid, nutrient, and vitamin blend — NOT a peptide blend. Provides complete methylation cycle coverage (Methionine + B12 + Choline/betaine + B6) that the 4X Recovery Blend lacks. Research Use Only (RUO). Updated April 2026.
Vitamin B12 (as methylcobalamin) is the cofactor for methionine synthase — the enzyme that remethylates homocysteine back to methionine using 5-methyltetrahydrofolate (5-MTHF) as the methyl donor. This reaction is the primary route by which homocysteine is recycled to methionine in most tissues. Without B12, homocysteine cannot be remethylated via methionine synthase, leading to homocysteine accumulation (hyperhomocysteinemia) even when methionine and choline are provided. In the 4X blend, the only homocysteine remethylation route available is the BHMT pathway (choline → betaine → methionine), which operates mainly in the liver and kidney, not in all tissues. In the 8X blend, B12 (1mg cyanocobalamin → methylcobalamin) provides the methionine synthase cofactor for ubiquitous homocysteine remethylation across all tissues. This is critical for research models studying: complete methylation cycle integrity; B12 deficiency’s impact on methylation and neurological function; or any system where homocysteine accumulation would confound interpretation of methylation outcomes.
Inositol (myo-inositol; 50mg; the highest-dose component in the 8X blend) serves several distinct metabolic roles: (1) It is the backbone of phosphatidylinositol (PI), a phospholipid membrane component that is the substrate for the PI3K/PIP2/IP3 signaling cascade. When PI3K (phosphatidylinositol 3-kinase) phosphorylates PI to generate PIP3, this activates Akt/PKB — the insulin receptor downstream signaling pathway. Inositol availability influences PI substrate supply for this cascade. (2) IP3 (inositol-1,4,5-trisphosphate) generated from PIP2 by PLC (phospholipase C) triggers ER Ca²+ release, activating multiple downstream signaling pathways including calcineurin/NFAT and calcium/calmodulin-dependent kinases. (3) In hepatocytes, inositol depletion impairs lipid metabolism and VLDL assembly, making it relevant to NAFLD and hepatic steatosis research. (4) Clinical research has documented effects of inositol supplementation on insulin sensitivity in PCOS models — suggesting the PI3K/insulin signaling connection is pharmacologically relevant. In the 8X blend, inositol complements the methionine/choline lipotropic components by also addressing the insulin receptor signaling dimension of hepatic lipid dysregulation.
Choose the 8X blend when: (1) the methylation cycle needs to be completely covered — if homocysteine disposal pathways (methionine synthase via B12; CBS via B6) need to be functional rather than cofactor-limited; (2) studying one-carbon metabolism dysfunction where B12 or B6 deficiency is a variable or where elevated homocysteine is a confounder to avoid; (3) inositol/PI3K/insulin signaling is a relevant dimension of the research question (the 4X has no inositol); (4) arginine/NO pathway research is needed alongside lipotropic effects; (5) the research requires a comprehensive metabolic panel rather than targeted lipotropic mechanism studies. Choose the 4X blend when: (1) the research question is specifically about the core lipotropic pathways (SAM methylation, hepatic VLDL export, carnitine FA transport, CoA availability) without needing cycle completion; (2) simpler experimental design with fewer components is preferred; (3) dexpanthenol (a B5 precursor form specific to 4X; 8X uses pantothenic acid directly) is preferred over pantothenic acid as the CoA precursor form.
Yes. YourPeptideBrand.com provides white-label dropship for the 8X Recovery Blend as YPB.267 (Research Use Only). White-label storefronts include pre-built RUO-compliant product pages with complete composition table, methylation cycle coverage narrative, and COA library links. This blend should be positioned as a comprehensive lipotropic nutrient research panel (not a peptide product). Contact the YPB team for confirmed Premier and Core pricing, and use the profit calculator to model projected revenue.
Every 8X Recovery Blend batch includes a lot-specific COA confirming all eight components by identity and purity (HPLC + MS for each component), total blend purity, endotoxin (<1 EU/mg), TAMC, and TYMC. The B12 component (cyanocobalamin; MW ~1,355 Da) requires MS confirmation given its complexity; B6 (pyridoxine; ~169 Da) and B5 (pantothenic acid; ~219 Da) are confirmed by HPLC. All lots are traceable through the batch-specific COA library.
Position the pair as the focused-to-comprehensive lipotropic research progression: 4X is the “precision lipotropic” — four core pathways for targeted fatty acid and methylation mechanism studies; 8X is the “complete metabolic panel” — eight pathways for comprehensive methylation cycle, insulin signaling, and NO pathway research. Both should be clearly labeled as lipotropic nutrient research blends (not peptide products). Key positioning: 4X for researchers studying specific lipotropic mechanism interventions; 8X for researchers studying the complete metabolic context of lipid dysfunction including methylation cycle integrity, insulin sensitivity, and vascular NO biology. The B12/B6/Inositol/Arginine additions in 8X are the differentiating features — these four components complete the methylation cycle (B12/B6), add insulin signaling (Inositol), and add NO pathway (Arginine) in ways that make 8X the appropriate choice when the research question extends beyond pure lipotropic mechanism to integrated metabolic panel coverage.
The 8X Recovery Blend is most appropriate for: (1) Complete methylation cycle research — where ensuring both remethylation routes (B12/methionine synthase; choline/BHMT) and the transsulfuration disposal route (B6/CBS) are fully supported; (2) Homocysteine metabolism and hyperhomocysteinemia models — where studying the effect of complete vs. partial B-vitamin support on homocysteine levels; (3) NAFLD/metabolic syndrome models where insulin resistance, methylation, NO bioavailability, and lipid export are all relevant simultaneously; (4) Inositol/PI3K signaling in metabolic disease — where the connection between PI substrate availability and insulin receptor downstream signaling is the research focus; (5) Research requiring the closest biochemical match to the full lipotropic injection formulations used historically in metabolic compound (which typically included MIC + B12 + B6); (6) Any study design where homocysteine accumulation from a methionine challenge would confound interpretation — the 8X provides complete homocysteine disposal cofactor coverage to prevent this.
Key Takeaways
Research Takeaways
- Complete methylation cycle coverage: Methionine (SAM entry) + B12 (methionine synthase remethylation) + Choline/betaine (BHMT remethylation) + B6 (CBS transsulfuration). 4X lacks B12 and B6.
- Two additional pathways vs. 4X: Inositol (PI/IP3/PI3K/insulin signaling) + Arginine (NOS/NO synthesis; urea cycle).
- B12 at 1mg (cyanocobalamin): Methionine synthase cofactor; closes methylation cycle remethylation route; also methylmalonyl-CoA mutase.
- B6 at 25mg (pyridoxine): CBS (homocysteine transsulfuration); PLP for >100 enzyme reactions.
- Inositol at 50mg (highest dose): PI/PI3K substrate; IP3/DAG; insulin receptor signaling.
- Not a peptide blend: Amino acids + essential nutrients + vitamins; lipotropic metabolic panel.
Business Takeaways
- Most comprehensive YPB lipotropic blend — complete methylation cycle + inositol + arginine + full lipotropic core.
- 4X (focused) → 8X (comprehensive) is the natural catalog upgrade path in the lipotropic category.
- Contact YPB for confirmed pricing on YPB.267.
Ready to add 8X Recovery Blend to your research catalog? Book a consultation with the YPB team.
[ypb_studies peptide=”8x-recovery-blend”]